祥生医疗: 祥生医疗2025年半年度募集资金存放与使用情况专项报告

Fundraising Overview - The company raised a total of RMB 1,010,600,000.00 from the issuance of 20,000,000 shares at RMB 50.53 per share in November 2019, with a net amount of RMB 939,858,000.00 after deducting underwriting fees [1][2] - As of June 30, 2025, the company has utilized RMB 743,396,639.01 of the raised funds, leaving a balance of RMB 208,065,730.16 in the special account [1][2] Fund Management - The company has established a management system for the raised funds, ensuring they are stored and used in compliance with relevant regulations [1][2] - A tripartite supervision agreement was signed with banks and the sponsor to manage the special account for the raised funds [1][2] Actual Use of Funds - The company has invested a total of RMB 4,984.45 million in the current year, with a cumulative investment of RMB 74,339.66 million as of the reporting date [3] - The company has replaced RMB 4,054,014.32 of self-raised funds used for project construction with the raised funds [1][3] Cash Management - The company approved the use of up to RMB 2.5 billion of temporarily idle raised funds and RMB 5 billion of idle self-owned funds for cash management, focusing on safe and liquid deposit products [2][3] - As of June 30, 2025, the company has invested RMB 72 million in structured deposits from idle raised funds [2][3] Project Status - The "Ultrasound Medical Imaging Equipment Industrialization Project" has been completed, and the remaining funds will be used to permanently supplement the company's working capital [3][4] - The company has not made any changes to the fundraising projects or transferred any funds externally during the reporting period [3]